Journal Selection & Manuscript Polishing Services
Medicine
Medicine
Back to journal directory
Review Cycle Records
Expert Review of Pharmacoeconomics & Outcomes Research
Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
31
days
Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults ≥65 years of age in Denmark
AuthorsOluwaseun Sharomi; Rachel J. Oidtman; John C. Lang; Kevin M. Bakker; Tufail Malik; Giulio Meleleo; Line Roesgaard Kantsø; Emilie Theisen Honore; Maja Holm Vinfeldt; Simone Ruth Flindhardt; Eleana Tsoumani
Affiliations1. Merck & Co., Inc; 2. Wolfram Research, Inc; 3. MSD Denmark; 4. MSD Greece
110
days
Cost-effectiveness analysis of sacituzumab tirumotecan as second-line therapy for EGFR-TKI–resistant, EGFR-mutated advanced NSCLC in China
AuthorsJing He; Jialin Yu; Ruixuan Liu; Qing Yang
Affiliations1. University of Electronic Science and Technology of China; 2. Chengdu University of Traditional Chinese Medicine
151
days
A brave new world: the rise of agentic AI in rapid cycle RWE analytics
AuthorsWon Chan Lee; Brent Mankin; David Hood
Affiliations1. Axtria Inc
77
days
TENS in chronic pain management: a 11-year nationwide analysis using the French National Health Data System
AuthorsVincent Arcani; Anne Donnet; Sylvain Redon
Affiliations1. Aix-Marseille Université, AP-HM, Hôpital de La Timone; 2. Aix-Marseille Université, INSERM 1263, INRAE 1260; 3. INSERM U-1107; 4. Université Côte d’Azur
168
days
Economic burden of breast cancer in Cyprus from a societal perspective
AuthorsYiola Marcou; Konstantinos Ferentinos; Evros Kitiris; Loukia Samata; Nikolas Koullouros
Affiliations1. Bank of Cyprus Oncology Center; 2. Department of Radiation Oncology; 3. European University Cyprus; 4. The Breast Center of Cyprus; 5. Novartis Pharma Services Inc. Cyprus
75
days
REFLECTIVE-TIAB: cost-effective prompt optimization for large language model-based title and abstract screening in literature reviews
AuthorsÁkos Józwiak; Attila Imre; Judit Hagymásy; Judit Tittmann; Ágnes Nagy; Sándor Kovács; Przemyslaw Kardas; Job FM. van Boven; Irene Mommers; Tamás Ágh
Affiliations1. University of Pecs; 2. Syreon Research Institute; 3. Semmelweis University; 4. Medical University of Lodz; 5. University Medical Center Groningen, University of Groningen
78
days
Differences in evidentiary requirements for oncology drug assessments across health technology assessment bodies in Germany, Spain, and France, the European Medicines Agency, and the EU Health Technology assessment regulation
AuthorsAmber Tiemens; Christophe Sauboin; Sharon Wolters; Simon James Bond; Judith Olga Maria Bentvelzen; Susana Monteiro; Seán Walsh; Maarten Jacobus Postma
Affiliations1. Asc Academics B.V; 2. University of Groningen, University Medical Center Groningen; 3. Boehringer Ingelheim International GmbH; 4. Boehringer Ingelheim Portugal; 5. Universitas Padjadjaran; 6. Universitas Airlangga; 7. University of Groningen
91
days
Pharmacoeconomics of high-cost therapies: real world challenges
AuthorsElvira Meni Maria Gkrinia; Andrej Belančić; Ivana Stević; Dinko Vitezić; Slobodan Janković
Affiliations1. Independent Researcher; 2. University of Rijeka; 3. University of Belgrade; 4. University of Kragujevac
146
days
Standardizing economic evaluation in Spain’s pharmaceutical pricing and reimbursement system: specification, interpretation and integration
AuthorsMarta Trapero-Bertran
Affiliations1. Universitat de Lleida
165
days
Budget impact analysis of capivasertib as a second-line therapy for advanced breast cancer in the United States
AuthorsTrang Nguyen; Shweta Mital
Affiliations1. University of Manitoba
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days